A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine

Clinical trial NCT05685953 · COMPLETED

Trial details

NCT number: NCT05685953
Sponsor: Matti Sällberg
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Respiratory Infection COVID-19 Vaccine Adverse Reaction

Start date: 2023-02-08
Primary completion: 2024-03-13
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.